These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12140762)

  • 21. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
    Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
    Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis.
    Kawase T; Ichikawa H; Ohta T; Nozaki N; Tashiro F; Ohki R; Taya Y
    Oncogene; 2008 Jun; 27(27):3797-810. PubMed ID: 18264133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
    Brazda V; Muller P; Brozkova K; Vojtesek B
    Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of p53 sequence-specific binding by DNA supercoiling.
    Palecek E; Brázda V; Jagelská E; Pecinka P; Karlovská L; Brázdová M
    Oncogene; 2004 Mar; 23(12):2119-27. PubMed ID: 14755248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites.
    Jagelská EB; Brázda V; Pecinka P; Palecek E; Fojta M
    Biochem J; 2008 May; 412(1):57-63. PubMed ID: 18271758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity.
    Flammer JR; Popova KN; Pflum MK
    Biochemistry; 2006 Aug; 45(31):9615-23. PubMed ID: 16878996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orchestration of Haemophilus influenzae RecJ exonuclease by interaction with single-stranded DNA-binding protein.
    Sharma R; Rao DN
    J Mol Biol; 2009 Feb; 385(5):1375-96. PubMed ID: 19094995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Itoh H; Kang D; Kohno K
    Cancer Res; 2003 Jul; 63(13):3729-34. PubMed ID: 12839966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.
    Janus F; Albrechtsen N; Knippschild U; Wiesmüller L; Grosse F; Deppert W
    Mol Cell Biol; 1999 Mar; 19(3):2155-68. PubMed ID: 10022902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complex interactions of p53 with target DNA: we learn as we go.
    Kim E; Deppert W
    Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter.
    Boggs K; Reisman D
    Oncogene; 2006 Jan; 25(4):555-65. PubMed ID: 16158047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant p53 proteins bind DNA in a DNA structure-selective mode.
    Göhler T; Jäger S; Warnecke G; Yasuda H; Kim E; Deppert W
    Nucleic Acids Res; 2005; 33(3):1087-100. PubMed ID: 15722483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
    Tang X; Molina M; Amar S
    Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.
    Baillat D; Laitem C; Leprivier G; Margerin C; Aumercier M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):213-7. PubMed ID: 19022222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex.
    Stehlíková K; Kaspárková J; Nováková O; Martínez A; Moreno V; Brabec V
    FEBS J; 2006 Jan; 273(2):301-14. PubMed ID: 16403018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Searching for target sequences by p53 protein is influenced by DNA length.
    Brázda V; Jagelská EB; Fojta M; Palecek E
    Biochem Biophys Res Commun; 2006 Mar; 341(2):470-7. PubMed ID: 16426567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori NikR's interaction with DNA: a two-tiered mode of recognition.
    Dosanjh NS; West AL; Michel SL
    Biochemistry; 2009 Jan; 48(3):527-36. PubMed ID: 19119856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.